Maven Securities’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-833
| Closed | -$48.8K | – | 334 |
|
|
2023
Q2 | $48.8K | Hold |
833
| – | – | ﹤0.01% | 242 |
|
|
2023
Q1 | $35.8K | Hold |
833
| – | – | ﹤0.01% | 195 |
|
|
2022
Q4 | $42.8K | Hold |
833
| – | – | ﹤0.01% | 202 |
|
|
2022
Q3 | $84K | Sell |
833
-500
| -38% | -$50.4K | ﹤0.01% | 398 |
|
|
2022
Q2 | $162K | Hold |
1,333
| – | – | ﹤0.01% | 311 |
|
|
2022
Q1 | $275K | Hold |
1,333
| – | – | 0.01% | 282 |
|
|
2021
Q4 | $266K | Sell |
1,333
-2,038
| -60% | -$407K | 0.01% | 285 |
|
|
2021
Q3 | $935K | Buy |
3,371
+1,204
| +56% | +$334K | 0.03% | 198 |
|
|
2021
Q2 | $793K | Sell |
2,167
-833
| -28% | -$305K | 0.03% | 255 |
|
|
2021
Q1 | $1.45M | Sell |
3,000
-2,750
| -48% | -$1.33M | 0.06% | 181 |
|
|
2020
Q4 | $3.71M | Buy |
+5,750
| New | +$3.71M | 0.37% | 63 |
|